• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechansim

ABPI_Incentivising_Antibioics_peter-pryharski-unsplash_landscape
Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 4th January 2016

OHE at the Health Economists’ Study Group (HESG) Meeting, Manchester 2016

A summary of OHE’s activity at the 2016 winter HESG meeting, Manchester, 6-8th January. OHE team members will play an active role in the forthcoming Health Economists’ Study Group (HESG) Meeting, Manchester, 6-8th January 2016. We have two papers being…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

A summary of OHE’s activity at the 2016 winter HESG meeting, Manchester, 6-8th January.

OHE team members will play an active role in the forthcoming Health Economists’ Study Group (HESG) Meeting, Manchester, 6-8th January 2016. We have two papers being discussed and a poster presentation; come to our sessions and learn about the public’s preferences for end of life care, projections of health care expenditure and the transferability and efficiency of HTA.  OHE attendees are also discussing other papers and will be available to answer questions about the wider OHE research programme.

OHE work being discussed is detailed below.


 

Do members of the general public wish to place greater weight on a unit of health gain for end-of-life patients than on that for other types of patients?

Authors: Koonal Shah, Aki Tsuchiya and Allan Wailoo.

Summary: The National Institute for Health and Care Excellence (NICE) has, since 2009, issued supplementary advice to its advisory committees regarding the appraisal of life-extending end of life treatments. NICE’s policy places additional weight on the survival benefits for patients with short life expectancy. It is unclear whether this reflects the preferences of the general public.

This paper reports the methods and preliminary results of a review of the published literature on this topic.

Discussant: J Nielsen

Time & location: Wednesday 6th January, 15:30, Galileo room


 

Projection of health care expenditure for OECD countries

Authors: Yan Feng, Toby Watt, Anita Charlesworth, Grace Marsden, Adam Roberts, Jon Sussex.

Summary: Constraining the rise in costs continues to be a major focus of health care policy in the UK, and internationally. It is important for governments to understand what is driving the rise in health care expenditure and what the impact will be over the coming years.

This paper has two main aims. Firstly to provide a developed econometric model to explain what drives changes in a country’s health expenditure and how. Secondly, to improve the projection of health care expenditure in 18 OECD countries in 2030.

Discussant: S Birch

Time & location: Thursday 7th January, 15:00, Galileo room


 

Value of Transferability and Efficiency in HTA

Authors: Bernarda Zamora, Grace Marsden, and Adrian Towse.

Summary: Existing literature on transferability advises that multinational trials should report country-specific cost-effectiveness results, yet typically these country specific results are only used to assess the between-location variability. 

We use value of information (VOI) analysis (assuming a normal distribution) to show that country specific results can be used to calculate the value of transferability (transfer from the wide trial to the country of interest) in terms of the Expected Value of Sample Information (EVSI).

This research is being presented as a poster.


 

OHE team members discussing others’ research:

To ‘name’ or ‘not to name’? Observed differences in health state values for multiple sclerosis states with and without condition labels

Authors: E Goodwin and C Green

Discussed by Koonal Shah, 6th January, 13:00, Bernini room

Efficient research design: a method for using value of information analysis within an adaptive study design to determine when sufficient data are collected

Author: E Wilson

Discussed by Bernarda Zamora, 6th January, 13:00, Raphael-Vasari room

Health care expenditures, age, proximity to death and morbidity: implications for an ageing population

Authors: D Howdon and N Rice

Discussed by Yan Feng, 7th January, 10:30, Michelangelo 2

What can NICE learn from VW: would new values for the EQ-5D mean a ‘recall’ for past cost-effectiveness decisions?

Authors: J Marti and P Kind

Discussed by Paula Lorgelly, 7th January, 11:30, Michelangelo 1

 

  • EQ-5D and PROMs
  • Presentations

Related News

  • News
  • March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Read more
  • News
  • March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Read more
  • News
  • January 2020

Funding Challenges in the Malaysian Health Care System

Read more
  • News
  • January 2020

OHE at HESG Winter 2020

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!